Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 16 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 7, 2026 20:08 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001813798-26-000023 · wk-form4_1791403730.xml · derivative · entry 3 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,398 Underlying: Common Stock · 18,000 shares Expires 2030-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:08 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
SaleCommon Stock | 18,000 | $86.74 | $1,561,320.00 |
DisclosureSEC source: 0001813798-26-000023 · wk-form4_1791403730.xml · nonDerivative · entry 2 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,435 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:08 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
Exercise / conversionCommon Stock | 18,000 | $5.35 | $96,300.00 |
DisclosureSEC source: 0001813798-26-000023 · wk-form4_1791403730.xml · nonDerivative · entry 1 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:07 UTC |
Cowan ElviaSVP, Finance & CAO
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,000 | $0.00 Strike: $25.92 | $0.00 |
DisclosureSEC source: 0001960048-26-000013 · wk-form4_1791403671.xml · derivative · entry 3 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,068 Underlying: Common Stock · 19,000 shares Expires 2032-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:07 UTC |
Cowan ElviaSVP, Finance & CAO
|
SaleCommon Stock | 19,000 | $86.74 | $1,648,060.00 |
DisclosureSEC source: 0001960048-26-000013 · wk-form4_1791403671.xml · nonDerivative · entry 2 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,860 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:07 UTC |
Cowan ElviaSVP, Finance & CAO
|
Exercise / conversionCommon Stock | 19,000 | $25.92 | $492,480.00 |
DisclosureSEC source: 0001960048-26-000013 · wk-form4_1791403671.xml · nonDerivative · entry 1 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:05 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001813798-26-000021 · wk-form4_1790971547.xml · derivative · entry 4 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,398 Underlying: Common Stock · 2,250 shares Expires 2030-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:05 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
SaleCommon Stock | 95 | $57.09 | $5,423.93 |
DisclosureSEC source: 0001813798-26-000021 · wk-form4_1790971547.xml · nonDerivative · entry 3 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,435 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $57.09 to $57.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:05 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
SaleCommon Stock | 2,155 | $56.65 | $122,089.37 |
DisclosureSEC source: 0001813798-26-000021 · wk-form4_1790971547.xml · nonDerivative · entry 2 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,530 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $56.065 to $56.955. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:05 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
Exercise / conversionCommon Stock | 2,250 | $5.35 | $12,037.50 |
DisclosureSEC source: 0001813798-26-000021 · wk-form4_1790971547.xml · nonDerivative · entry 1 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2026 Filed Sep 9, 2026 21:46 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
SaleCommon Stock | 1,334 | $59.52 | $79,401.01 |
DisclosureSEC source: 0001813798-26-000019 · wk-form4_1788990392.xml · nonDerivative · entry 3 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,435 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F4 · shares: The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:56 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 17,056 | $60.36 | $1,029,500.16 |
DisclosureSEC source: 0001258693-26-000019 · wk-form4_1788990967.xml · nonDerivative · entry 1 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,902 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:54 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
Tax withholdingCommon Stock | 7,155 | $60.36 | $431,875.80 |
DisclosureSEC source: 0001230724-26-000018 · wk-form4_1788990858.xml · nonDerivative · entry 1 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,316 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:53 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
Tax withholdingCommon Stock | 7,651 | $60.36 | $461,814.36 |
DisclosureSEC source: 0001886794-26-000012 · wk-form4_1788990788.xml · nonDerivative · entry 1 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,085 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:52 UTC |
Cowan ElviaSVP, Finance & CAO
|
Tax withholdingCommon Stock | 1,327 | $60.36 | $80,097.72 |
DisclosureSEC source: 0001960048-26-000011 · wk-form4_1788990731.xml · nonDerivative · entry 1 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,860 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:46 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
Tax withholdingCommon Stock | 5,459 | $60.36 | $329,505.24 |
DisclosureSEC source: 0001813798-26-000019 · wk-form4_1788990392.xml · nonDerivative · entry 2 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,769 F3 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:46 UTC |
Wassil JimEVP, Chief Scientific Ofc, COO
|
SaleCommon Stock | 1,381 | $61.16 | $84,461.96 |
DisclosureSEC source: 0001813798-26-000019 · wk-form4_1788990392.xml · nonDerivative · entry 1 Wassil Jim · CIK 0001813798 · EVP, Chief Scientific Ofc, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,228 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F2 · shares: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:40 UTC |
Jodar LuisChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 88,254 | $0.00 Strike: $61.16 | $0.00 |
DisclosureSEC source: 0002151661-26-000004 · wk-form4_1788990021.xml · derivative · entry 2 Jodar Luis · CIK 0002151661 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,254 Underlying: Common Stock · 88,254 shares Expires 2036-09-04 F2 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:40 UTC |
Jodar LuisChief Medical Officer
|
GrantCommon Stock | 52,632 | $0.00 | $0.00 |
DisclosureSEC source: 0002151661-26-000004 · wk-form4_1788990021.xml · nonDerivative · entry 1 Jodar Luis · CIK 0002151661 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,632 F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. Read SEC document |
| September 02, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 1,432 | $61.58 | $88,182.56 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 7 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,609 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 02, 2026 Filed Sep 2, 2026 23:57 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 3,427 | $61.58 | $211,034.66 |
DisclosureSEC source: 0001258693-26-000017 · wk-form4_1788393451.xml · nonDerivative · entry 2 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,958 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 02, 2026 Filed Sep 2, 2026 23:56 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
Tax withholdingCommon Stock | 1,432 | $61.58 | $88,182.56 |
DisclosureSEC source: 0001230724-26-000016 · wk-form4_1788393412.xml · nonDerivative · entry 2 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,471 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 02, 2026 Filed Sep 2, 2026 23:56 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
Tax withholdingCommon Stock | 659 | $61.58 | $40,581.22 |
DisclosureSEC source: 0001886794-26-000010 · wk-form4_1788393367.xml · nonDerivative · entry 2 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,736 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 02, 2026 Filed Sep 2, 2026 23:54 UTC |
Cowan ElviaSVP, Finance & CAO
|
Tax withholdingCommon Stock | 326 | $61.58 | $20,075.08 |
DisclosureSEC source: 0001960048-26-000009 · wk-form4_1788393289.xml · nonDerivative · entry 2 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,187 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · derivative · entry 8 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,648 Underlying: Common Stock · 2,250 shares Expires 2030-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 303 | $61.42 | $18,611.47 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 6 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,041 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F6 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 924 | $60.96 | $56,322.42 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 5 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,344 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F5 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 713 | $61.48 | $43,835.95 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 4 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,268 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 1,537 | $60.89 | $93,581.78 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 3 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,981 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 2,250 | $5.35 | $12,037.50 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 2 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:58 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Tax withholdingCommon Stock | 1,273 | $60.74 | $77,322.02 |
DisclosureSEC source: 0001813798-26-000017 · wk-form4_1788393516.xml · nonDerivative · entry 1 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,268 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:57 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 2,862 | $60.74 | $173,837.88 |
DisclosureSEC source: 0001258693-26-000017 · wk-form4_1788393451.xml · nonDerivative · entry 1 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,385 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:56 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
Tax withholdingCommon Stock | 1,273 | $60.74 | $77,322.02 |
DisclosureSEC source: 0001230724-26-000016 · wk-form4_1788393412.xml · nonDerivative · entry 1 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,903 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:56 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
Tax withholdingCommon Stock | 361 | $60.74 | $21,927.14 |
DisclosureSEC source: 0001886794-26-000010 · wk-form4_1788393367.xml · nonDerivative · entry 1 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,395 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:54 UTC |
Cowan ElviaSVP, Finance & CAO
|
Tax withholdingCommon Stock | 243 | $60.74 | $14,759.82 |
DisclosureSEC source: 0001960048-26-000009 · wk-form4_1788393289.xml · nonDerivative · entry 1 Cowan Elvia · CIK 0001960048 · SVP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,513 F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. F2 · balance_after: Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| August 05, 2026 Filed Aug 5, 2026 23:01 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $24.79 | $0.00 |
DisclosureSEC source: 0001886794-26-000008 · wk-form4_1785970896.xml · derivative · entry 3 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 17,000 shares Expires 2032-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| August 05, 2026 Filed Aug 5, 2026 23:01 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
SaleCommon Stock | 17,000 | $55.00 | $935,068.00 |
DisclosureSEC source: 0001886794-26-000008 · wk-form4_1785970896.xml · nonDerivative · entry 2 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,756 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2026 Filed Aug 5, 2026 23:01 UTC |
Dhaliwal Harpreet S.Chief Technical Ops Officer
|
Exercise / conversionCommon Stock | 17,000 | $24.79 | $421,430.00 |
DisclosureSEC source: 0001886794-26-000008 · wk-form4_1785970896.xml · nonDerivative · entry 1 Dhaliwal Harpreet S. · CIK 0001886794 · Chief Technical Ops Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:59 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,250 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001813798-26-000015 · wk-form4_1785963547.xml · derivative · entry 4 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,898 Underlying: Common Stock · 2,250 shares Expires 2030-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock Option is fully vested and exercisable. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:59 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 1,389 | $54.09 | $75,129.62 |
DisclosureSEC source: 0001813798-26-000015 · wk-form4_1785963547.xml · nonDerivative · entry 3 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,541 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $53.935 to $54.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:59 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
SaleCommon Stock | 861 | $53.50 | $46,065.22 |
DisclosureSEC source: 0001813798-26-000015 · wk-form4_1785963547.xml · nonDerivative · entry 2 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 158,930 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $52.915 to $53.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:59 UTC |
Wassil JimCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock | 2,250 | $5.35 | $12,037.50 |
DisclosureSEC source: 0001813798-26-000015 · wk-form4_1785963547.xml · nonDerivative · entry 1 Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 159,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:58 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.35 | $0.00 |
DisclosureSEC source: 0001230724-26-000014 · wk-form4_1785963491.xml · derivative · entry 5 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,827 Underlying: Common Stock · 10,000 shares Expires 2030-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option is fully vested and exercisable. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:58 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
SaleCommon Stock | 3,044 | $54.18 | $164,917.83 |
DisclosureSEC source: 0001230724-26-000014 · wk-form4_1785963491.xml · nonDerivative · entry 3 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,176 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026. F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $54.07 to $54.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:58 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
SaleCommon Stock | 6,956 | $53.76 | $373,961.52 |
DisclosureSEC source: 0001230724-26-000014 · wk-form4_1785963491.xml · nonDerivative · entry 2 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,220 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026. F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:58 UTC |
GUGGENHIME ANDREWPRESIDENT AND CFO
|
Exercise / conversionCommon Stock | 10,000 | $5.35 | $53,500.00 |
DisclosureSEC source: 0001230724-26-000014 · wk-form4_1785963491.xml · nonDerivative · entry 1 GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:10 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,198 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001258693-26-000015 · wk-form4_1785269436.xml · derivative · entry 8 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,000 Underlying: Common Stock · 16,198 shares Expires 2028-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Option is fully vested and exercisable. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:10 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 378 | $55.91 | $21,135.49 |
DisclosureSEC source: 0001258693-26-000015 · wk-form4_1785269436.xml · nonDerivative · entry 7 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Children's Trust Disclosed balance after: 133,215 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. F9 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $55.82 to $56.085. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F8 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:10 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 622 | $55.54 | $34,545.88 |
DisclosureSEC source: 0001258693-26-000015 · wk-form4_1785269436.xml · nonDerivative · entry 6 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Children's Trust Disclosed balance after: 133,593 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. F5 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F8 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:10 UTC |
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 244 | $55.96 | $13,655.22 |
DisclosureSEC source: 0001258693-26-000015 · wk-form4_1785269436.xml · nonDerivative · entry 5 PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Children's Trust Disclosed balance after: 133,215 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. F7 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $55.81 to $56.18. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F6 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.